Wire Stories

Category Added in a WPeMatico Campaign

news_6

BioAtla and BeiGene Revise Global Development and Commercialization Agreement for Novel Conditionally Active Biologic CTLA-4 Candidate BA3071

SAN DIEGO & BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--$BGNE #BGNE--BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of...